Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Total revenue	$ 14,180,480	$ 14,768,693
Total cost of revenue	1,952,276	1,827,478
Gross profit	12,228,204	12,941,215
Operating expenses:
Research and development costs	2,833,643	2,467,783
Selling and marketing	5,672,023	4,601,228
General and administrative	2,887,957	3,022,350
Gain on litigation settlement	(632,600)	0
Restructuring costs	833,313	1,032,826
Total operating expenses	11,594,336	11,124,187
Operating income (loss)	633,868	1,817,028
Gain on debt extinguishment	754,000	0
Interest and other expense	(657,773)	(748,621)
Income (loss) before income taxes	730,095	1,068,407
Income tax expense (benefit)	526,763	(14,319)
Net income (loss)	203,332	1,082,726
Less: Accrual of Series A redeemable convertible preferred stock dividends	1,143,697	1,083,892
Less: Accretion to redemption value of Series A redeemable convertible preferred stock	299,969	552,551
Net income (loss) attributable to common stockholders	$ (1,240,334)	$ (553,717)
Earnings per share
Basic net income (loss) per share attributable to common stockholders	$ (0.19)	$ (0.09)
Diluted net income (loss) per share attributable to common stockholders	$ (0.19)	$ (0.09)
Weighted average basic shares outstanding	6,515,274	5,920,517
Weighted average diluted shares outstanding	6,515,274	5,920,517
Product
Total revenue	$ 7,254,471	$ 7,097,695
Total cost of revenue	325,089	297,555
Support and service
Total revenue	6,926,009	7,670,998
Total cost of revenue	$ 1,627,187	$ 1,529,923